Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CDER Succession: Woodcock's Responsibilities Mount With No Clear #2 In Sight

FDA entrance sign 2016

Related Content

CDER Taps Genzyme Exec As Deputy Director For Science Operations

Feb 13 2013

Woodcock's 'Bias' In Sarepta Case Made Jenkins Worry About Future Drug Reviews

Aug 01 2017

Merck R&D Exec Jumps To US FDA As Office Of New Drugs Deputy Director

Nov 09 2016

Related Companies

Sanofi Genzyme

Merck & Co., Inc.

Sarepta Therapeutics, Inc.

Additional Topics

United States Leadership FDA Regulation BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window